FORT LEE, N.J.--(BUSINESS WIRE)--The role of SAFE-BioPharma interoperable digital identities in assuring secure cloud computing will be featured at Cambridge Healthtech Institute’s Molecular Medicine Tri-Conference, Sunday, February 19, at Moscone Center in San Francisco. The Molecular Medicine Tri-Conference is one of the key life science industry meetings covering the latest trends, technologies, research breakthroughs, regulatory issues, and best practice examples of molecular and translational medicine advances.
